Abstract A087: Leveraging conformation selectivity of MAPK-targeting inhibitors for tumor-selective targeting of RAS-mutant cancers
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Author: Poulikos I. Poulikakos
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444379
Cites:
Cited by:
Related to: